Lessons from experiences of accessing healthcare during the pandemic for remobilizing rheumatology services: a national mixed methods study
暂无分享,去创建一个
G. Macfarlane | Marcus John Beasley | Gareth T. Jones | P. Murchie | LaKrista Morton | R. Hollick | Kevin Stelfox | J. Paton | G. Jones | K. Stelfox
[1] M. Limb. Delayed discharge: how are services and patients being affected? , 2022, BMJ.
[2] C. Gordon,et al. Will ‘the feeling of abandonment’ remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and clinicians , 2022, Rheumatology.
[3] H. Marzo-Ortega,et al. Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1) , 2021, Rheumatology advances in practice.
[4] J. Newton,et al. Inequalities in excess premature mortality in England during the COVID-19 pandemic: a cross-sectional analysis of cumulative excess mortality by area deprivation and ethnicity , 2021, BMJ Open.
[5] C. Gordon,et al. Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians , 2021, Rheumatology.
[6] L. Trupin,et al. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases , 2021, The Lancet Rheumatology.
[7] K. Oxtoby. Covid-19: “Life on hold” for NHS patients needing musculoskeletal care , 2021, BMJ.
[8] Joseph P. Wherton,et al. Expanding Video Consultation Services at Pace and Scale in Scotland During the COVID-19 Pandemic: National Mixed Methods Case Study , 2021, Journal of medical Internet research.
[9] F. Naughton,et al. Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study , 2021, BMJ Open.
[10] G. Macfarlane,et al. The BSR-PsA: study protocol for the British Society for Rheumatology psoriatic arthritis register , 2021, BMC Rheumatology.
[11] M. Danila,et al. Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID‐19 Pandemic in a Community Practice–Based Network , 2021, Arthritis care & research.
[12] G. Macfarlane,et al. The effect of COVID-19 public health restrictions on the health of people with musculoskeletal conditions and symptoms: the CONTAIN study , 2021, Rheumatology.
[13] L. Carmona,et al. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) , 2021, RMD Open.
[14] I. Scott,et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review , 2021, BMJ Open.
[15] J. Bateman,et al. Managing patients using telerheumatology: Lessons from a pandemic , 2021, Best Practice & Research Clinical Rheumatology.
[16] C. Gordon,et al. The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study , 2020, Rheumatology advances in practice.
[17] P. Merkel,et al. Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic , 2020, The Journal of Rheumatology.
[18] A. Boonen,et al. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries , 2020, Annals of the Rheumatic Diseases.
[19] Devin M Mann,et al. COVID-19 transforms health care through telemedicine: Evidence from the field , 2020, J. Am. Medical Informatics Assoc..
[20] G. Macfarlane,et al. Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials? , 2020, Annals of the Rheumatic Diseases.
[21] A. Ogdie,et al. Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic , 2020, ACR open rheumatology.
[22] Virginia Braun,et al. To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales , 2019 .
[23] G. Prescott,et al. The Maintaining Musculoskeletal Health (MAmMOTH) Study: Protocol for a randomised trial of cognitive behavioural therapy versus usual care for the prevention of chronic widespread pain , 2016, BMC Musculoskeletal Disorders.
[24] G. Macfarlane,et al. The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment , 2015, BMC Musculoskeletal Disorders.
[25] M. Englund,et al. Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population , 2012, Annals of the rheumatic diseases.
[26] G. Bonsel,et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.
[27] J. Gafaranga,et al. Comparison of face-to-face and telephone consultations in primary care: qualitative analysis. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.
[28] R. Hays,et al. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items , 2009, Quality of Life Research.
[29] W. Warburton,et al. Understanding and sustaining the health care service shifts accelerated by COVID-19 , 2020 .